Join to View Full Profile
243 Charles StBoston, MA 02114
Phone+1 617-523-7900
Dr. Yin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Cornea, External Diseases, and Refractive Surgery, 2015 - 2017
Detroit Medical Center/Wayne State UniversityResidency, Ophthalmology, 2012 - 2015- Detroit Medical Center/Wayne State University (Sinai-Grace)Internship, Transitional Year, 2011 - 2012
Wayne State UniversityPh.D., Vision science, 2008
Capital University of Medical SciencesClass of 2003
Certifications & Licensure
MA State Medical License 2015 - 2025
MI State Medical License 2011 - 2015
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Central Cornea Changes on Anterior Segment OCT and In Vivo Confocal Microscopy After Autologous Limbal Epithelial Cell Transplantation.Leyla Yavuz Saricay, Aaron R Kaufman, Lynette K Johns, Jia Yin, Lassana Samarakoon
Cornea. 2025-03-28 - Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal tem cell deficiency: a phase I/II clinical trial of the first xenobiotic-free, serum-fr...Ula V Jurkunas, Aaron R Kaufman, Jia Yin, Allison Ayala, Maureen Maguire
Nature Communications. 2025-03-04 - Nerve Growth Factor Treatment for Neurotrophic Keratopathy in the IRIS® Registry.Asmaa A Zidan, Joshua B Gilbert, Eric Goldberg, Connor Ross, Tobias Elze
Ophthalmology. 2025-03-01
Journal Articles
- Association of Α-melanocyte–Stimulating Hormone with Corneal Endothelial Cell Survival During Oxidative Stress and Inflammation-Induced Cell Loss in Donor TissueUla V Jurkunas, Jia Yin, Reza Dana, JAMA Ophthalmology
Press Mentions
HMN 2025: How Novel Stem Cell Remedy Repairs ‘Irreversible’ Corneal Harm in Scientific TrialMarch 5th, 2025- Novel Stem Cell Therapy Repairs Irreversible Corneal Damage in Clinical TrialMarch 4th, 2025
- Stem Cell Therapy Repairs Blinding Corneal Damage in TrialMarch 4th, 2025
- Join now to see all
Grant Support
- Tissue Hypoxia and Topical Oxygen Therapy in Ocular Mustard Gas InjurySCHEPENS EYE RESEARCH INSTITUTE2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
